Application-based market taxonomy segments demand into clinical diagnostics, research, and forensic workflows, each exhibiting distinct pricing power and growth vectors. Clinical diagnostics generates the highest price premium: labs processing infectious-disease or oncology panels prioritize certified plates with RNase-/DNase-free guarantees and bar-coded traceability, pushing average selling prices 25–30 % above research grades; this segment captured 42 % of 2023 market revenue. Research use, spanning gene-expression, genotyping, and mutagenesis studies, is volume-led but price-sensitive, relying on bulk purchasing contracts; it still accounts for 48 % of revenues because of experiment repetition and protocol optimization cycles. Forensic applications, though niche, demand ultra-low-binding surfaces and tamper-evident sealing to meet chain-of-custody standards, commanding per-unit prices on par with clinical grades yet contributing 10 % of market value as national DNA database expansions sustain mid-single-digit annual growth.